ChemoMetec A/S (CPH:CHEMM)
Denmark · Delayed Price · Currency is DKK 647.50
-4.50 (-0.69%)
Oct 15, 2025, 4:59 PM CET
ChemoMetec Market Cap
ChemoMetec has a market cap or net worth of 11.27 billion as of October 15, 2025. Its market cap has increased by 58.31% in one year.
Market Cap
11.27B
Enterprise Value
10.93B
Revenue
495.57M
Ranking
n/a
PE Ratio
60.46
Stock Price
647.50
Market Cap Chart
Since December 18, 2006, ChemoMetec's market cap has increased from 374.48M to 11.27B, an increase of 2,908.97%. That is a compound annual growth rate of 19.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2025 | 11.35B | 34.10% |
| Dec 30, 2024 | 8.46B | 25.31% |
| Dec 29, 2023 | 6.75B | -43.81% |
| Dec 30, 2022 | 12.02B | -17.11% |
| Dec 30, 2021 | 14.50B | 44.12% |
| Dec 30, 2020 | 10.06B | 211.46% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1,659.84B |
| Coloplast | 128.35B |
| Genmab | 127.85B |
| Demant | 47.72B |
| ALK-Abelló | 46.98B |
| H. Lundbeck | 43.22B |
| Zealand Pharma | 34.74B |
| Ambu A/S | 27.09B |